Lv1
30 积分 2025-03-16 加入
Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database
3个月前
已完结
Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort study
3个月前
已完结
Chitinase 3–Like 1 Promotes Endothelial‐to‐Mesenchymal Transition in Systemic Sclerosis via Mechanistic Target of Rapamycin Complex 1 Signaling Pathway
6个月前
已完结
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
6个月前
已完结
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
6个月前
已完结
Application of blinatumomab, a bispecific anti-CD3/CD19 T-cell engager, in treating severe systemic sclerosis: A case study
6个月前
已完结
T-cell-engaging bispecific antibodies in cancer
6个月前
已完结
Spatially informed phenotyping by cyclic-in-situ-hybridisation identifies novel fibroblast populations and their pathogenic niches in systemic sclerosis
7个月前
已完结
Spatial multiomics decipher fibroblast–macrophage dynamics in systemic sclerosis
7个月前
已完结
Combining systemic and locally applied cellular therapies for the treatment of systemic sclerosis
7个月前
已完结
皖公网安备34019202002308
